Skip to main content
Log in

Ibuprofen in very preterm infants impairs renal function for the first month of life

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We carried out a study aiming to determine the renal effect of ibuprofen treatment for patent ductus arteriosus (PDA) in very preterm infants during the first month of life. Infants aged 27−31 weeks gestation were enrolled from October 2004 to August 2006. They were assigned to two different groups according to ibuprofen exposure during care of their PDA status assessed by echocardiography. Infants of both groups were matched based on gestational age, Clinical Risk Index for Babies score, birth weight and inclusion center. Renal function was evaluated at baseline and weekly for 1 month. One hundred and forty-eight infants were enrolled. Glomerular filtration rate (GFR) was significantly decreased in the ibuprofen group after treatment withdrawal (GFR on day 7, ibuprofen versus no ibuprofen: 12.8 ± 6.2 vs. 18.1 ± 12.1 ml/min/1.73 m2; P < 0.001). Adjusted analysis proved this decrease to be sustained during the first month of life. Tubular function was also impaired during the first month in ibuprofen-treated infants. Ibuprofen administered for PDA is associated with a decreased GFR during the first month of life. Renal function of infants receiving ibuprofen should be carefully monitored and drugs that are eliminated by glomerular filtration handled cautiously during this period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE (1976) Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 295:526–529

    Article  CAS  Google Scholar 

  2. Heymann MA, Rudolph AM, Silverman NH (1976) Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295:530–533

    Article  CAS  Google Scholar 

  3. Gersony M, Peckham J, Curtis Ellison R, Miettinen S, Nadas S (1983) Effects of Indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr 102:895–906

    Article  CAS  Google Scholar 

  4. Danilowicz D, Rudolph AM, Hoffman JI (1966) Delayed closure of the ductus arteriosus in premature infants. Pediatrics 37:74–78

    CAS  PubMed  Google Scholar 

  5. Krovetz LJ, Rowe RD (1972) Patent ductus, prematurity and pulmonary disease. N Engl J Med 287:513–514

    Article  CAS  Google Scholar 

  6. Brown ER (1979) Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 95:865–866

    Article  CAS  Google Scholar 

  7. Van Overmeire B, Follens I, Hartmann S, Creten W, Van Acker KJ (1997) Treatment of patent ductus arteriosus with Ibuprofen. Arch Dis Child 76:F179–F184

    Article  Google Scholar 

  8. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674–681

    Article  Google Scholar 

  9. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, Rubaltelli FF, Intraventricular Ibuprofen Study Group (2005) Prophylactic ibuprofen for the prevention of IVH among preterm infants: a multicenter, randomized study. Pediatrics 115:1529–1535

    Article  Google Scholar 

  10. Iacobelli S, Bonsante F, Ferdinus C, Labenne M, Gouyon JB (2009) Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks. J Perinatol 29:232–236

    Article  CAS  Google Scholar 

  11. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli R (1999) Effects of Indomethacin and Ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733–738

    Article  CAS  Google Scholar 

  12. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–938

    Article  Google Scholar 

  13. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, Blanc T, Fichtner C, Savagner C, Gouyon JB, Flurin V, Thiriez G (2004) Multicentric prospective randomized double blind trial comparing prophylactic ibuprofen versus curative ibuprofen in very premature infants less than 28 weeks of gestation. Lancet 364:1939–1944

    Article  CAS  Google Scholar 

  14. Allegaert K, Rayyan M, Anderson BJ (2006) Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Methods Find Exp Clin Pharmacol 28:519–522

    Article  CAS  Google Scholar 

  15. Ohlsson A, Walia R, Shah S (2008) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (1):CD003481

  16. Antonucci R, Cuzzolin L, Arceri A, Dessi A, Fanos V (2009) Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductis arteriosus. Eur J Clin Pharmacol 65:223–230

    Article  CAS  Google Scholar 

  17. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, Carlo WA, Ward RM, Shalwitz R, Baggs G, Seth A, Darko L (2009) A randomized, double-blind, placebo-controlled trial on IV ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26:235–245

    Article  Google Scholar 

  18. Bueva A, Guignard JP (1994) Renal function in preterm neonates. Pediatr Res 36:572–577

    Article  CAS  Google Scholar 

  19. Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774–779

    Article  CAS  Google Scholar 

  20. Su BH, Watanabe T, Shimizu M, Yanagisawa M (1997) Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed 77:F36–F40

    Article  CAS  Google Scholar 

  21. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422

    Article  CAS  Google Scholar 

  22. Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM (2003) Dose-finding study of Ibuprofen in patent ductus arteriosus. Biol Neonate 84:272

    Google Scholar 

  23. The International Neonatal Network (1993) The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 342:193–198

    Article  Google Scholar 

  24. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    Article  CAS  Google Scholar 

  25. Ojala R, Ala-Houhala M, Harmoinen AP, Luukkaala T, Uotila T, Tammela O (2006) Tubular proteinuria in pre-term and full-term infants. Pediatr Nephrol 21:68–73

    Article  Google Scholar 

  26. Guignard JP, Drukker A (1999) Why do newborn infants have a high plasma creatinine? Pediatrics 103:e49

    Article  CAS  Google Scholar 

  27. Guignard JP (1982) Renal function in the newborn infant. Pediatr Clin North Am 29:777–790

    Article  CAS  Google Scholar 

  28. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A, Weyler J, Harrewijn I, Langhendries JP (2004) Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 364:1945–1949

    Article  Google Scholar 

  29. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161:202–207

    Article  CAS  Google Scholar 

  30. Deschaux M (1994) Explorations fonctionnelles rénales chez l’enfant. Editions techniques, Encycl Med Chir, Pediatrie 4-083-J-10, 4p

  31. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121

    Article  Google Scholar 

  32. Guignard JP, Mattheova E (2002) Postnatal adaptation of the kidney. ESPN Handbook, Medcom, Lyon, France, pp 37–43

  33. Kempley ST, Gamsu HR, Nicolaides KH (1993) Renal artery blood flow velocity in very low birthweight infants with intrauterine growth retardation. Arch Dis Child 68:588–590

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel Vieux.

Additional information

This study was registered with the ClinicalTrials.gov registry (Number: NCT00217191) and funded by the French National Hospital Clinical Research Program (PHRC 17-6, year 2004). No author has conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vieux, R., Desandes, R., Boubred, F. et al. Ibuprofen in very preterm infants impairs renal function for the first month of life. Pediatr Nephrol 25, 267–274 (2010). https://doi.org/10.1007/s00467-009-1349-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1349-9

Keywords

Navigation